Who has invested in HanBio Therapeutics?

OrbiMed, Hankang Capital, Yonghua Investment, Elikon Investment are named among the investors backing HanBio Therapeutics.

HanBio Therapeutics Funding: $40M Raised, Series A (2022)

HanBio Therapeutics funding overview

HanBio Therapeutics is based in Shanghai, China. HanBio Therapeutics has raised $40M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2022. The round record for HanBio Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include OrbiMed, Hankang Capital, Yonghua Investment, Elikon Investment. 4 distinct backers are named across the disclosed rounds.

HanBio Therapeutics at a glance

Total raised: $40M
Latest round: Series A
Latest round date: January 2022
Headquarters: Shanghai, China
Notable investors: OrbiMed, Hankang Capital, Yonghua Investment, Elikon Investment

Frequently asked about HanBio Therapeutics funding

How much has HanBio Therapeutics raised?: HanBio Therapeutics has raised $40M in total disclosed funding across the rounds on record.
Who has invested in HanBio Therapeutics?: OrbiMed, Hankang Capital, Yonghua Investment, Elikon Investment are named among the investors backing HanBio Therapeutics.
What was the latest HanBio Therapeutics funding round?: The most recent disclosed round is a Series A, announced in January 2022.
Where is HanBio Therapeutics based?: HanBio Therapeutics is based in Shanghai, China.
When did HanBio Therapeutics last raise?: The last disclosed HanBio Therapeutics round closed in January 2022 at Series A.

HanBio Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Shanghai below to benchmark round size and investor mix.

HanBio Therapeutics Funding: $40M Raised, Series A (2022)

HanBio Therapeutics funding overview

HanBio Therapeutics at a glance

Frequently asked about HanBio Therapeutics funding

Companies related to HanBio Therapeutics (36)

Browse related funding lists (5)